Aclarion partnered with the Institute of Neuro Innovation in Santa Monica, Calif., according to a June 3 news release.
Amir Vokshoor, MD, who leads the institute, will use SPECT-CT and Aclarion’s Nociscan in conjunction to support physicians treating chronic lower back pain patients. Nociscan is a tool used to measure pain-related chemical biomarkers inside each lumbar disc.
“Chronic low back pain has become one of the most common issues we treat,” Dr. Vokshoor, said in the release. “Status quo diagnostic tools, like MRI, cannot always provide clear diagnostic insights to the complex spinal anatomy. The industry has adopted other tools, like SPECT-CT, which have proven to have value, but limited applicability. We are pleased to add MR Spectroscopy and Nociscan to our armamentarium. The peer-reviewed, published evidence supporting Nociscan is compelling and we look forward to experiencing the differentiated value it provides compared with other tests like MRI and SPECT-CT.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
